Pharma dose CMOs face growth slowdown, but opportunities lie ahead
GlobalData’s expert trend report reveals that the slowdown marks a sharp contrast to the rapid growth seen in 2020-22
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Recipharm
M&A activity of pharma CMOs will continue despite challenging borrowing environment: GlobalData
CMOs showed an increasing reluctance to take on debt in 2022. Even still, large CMOs made acquisitions of companies and facilities…
Healthcare industry records 103 deals worth $55.3 billion in December 2020
One big-ticket deal contributes 70.5 per cent of the total deal value in December 2020
Recipharm, Moderna sign deal for manufacturing, fill-finish of COVID-19 vaccines
They have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 vaccine supply outside of the…
EQT makes $2.8 bn bid for Recipharm
EQT said it was bidding 220 crowns per Recipharm share, a 22.9 per cent premium to Recipharm’s closing price
Learning to live with COVID-19
Can COVID-19 push us towards the unthinkable: a patent-free vaccine or patent-free drug?
Share savings programme to attract best talent: Mark Quick, Recipharm
The share savings programme had a positive effect on employee retention, while also increasing the sense of ownership and…
Recipharm expands Indian injectable dosage form capabilities through new partnership
The new facility that will be established in Dehradun, Uttarakhand, in northern India, is expected to be fully operational by 2022…
7th Pharma Pro & Pack Expo held in Bengaluru
During a panel discussion, experts discussed about new technologies, challenges in incorporating quality and compliance. It was…
Newer technology will disrupt the pharma manufacturing process
During the panel discussion experts discusses about New technologies: Challenges in incorporating quality and compliance. It was…